Pharma Foods International Co., Ltd.

As of January 31, 2025, Pharma Foods International Co., Ltd. carries a market capitalization of 28.65B, placing it among publicly traded companies globally. Its enterprise value stands at 29.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Pharma Foods International Co., Ltd.'s next confirmed earnings release is scheduled for December 16, 2026.

As of January 31, 2025, Pharma Foods International Co., Ltd. has 29.06M shares outstanding.

These figures are as of January 31, 2025.

As of January 31, 2025, Pharma Foods International Co., Ltd. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended January 31, 2025.

Over the twelve months ended January 31, 2025, Pharma Foods International Co., Ltd. recorded 1.05B in income tax expense.

As of the close on October 22, 2026, Pharma Foods International Co., Ltd.'s stock has declined approximately 18.12% over the past 52 weeks. The 50-day moving average sits at 654.56, while the 200-day moving average is 639.33.

As of January 31, 2025, Pharma Foods International Co., Ltd. holds 11.11B in cash and equivalents against 12.44B in total debt, resulting in a net debt position of 1.34B. Total book value stands at 12.05B, with working capital of 3.82B providing operational flexibility.

Pharma Foods International Co., Ltd.'s most recent stock split took place on January 28, 2015 with a 1:2 split ratio.